NCT03458585

Brief Summary

This questionnaire is aimed at finding out if patients understand how much radiation they are being exposed to when they have a bone scan (99mTc-MDP)or an FDG PET/CT scan (18F-FDG PET/CT). This questionnaire is also interested in understanding if patients consider current leaflet information sent with appointment letter as sufficient to understand what the radiation dose from that scan is. By collecting information on how much patients are aware and understand about radiation exposure, we can use this information to develop better guidance for medical staff who advise patients as well as clearer information leaflets for patients to assist in their understanding.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 20, 2018

Completed
6 days until next milestone

Study Start

First participant enrolled

February 26, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 8, 2018

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

June 29, 2018

Status Verified

March 1, 2018

Enrollment Period

10 months

First QC Date

February 20, 2018

Last Update Submit

June 28, 2018

Conditions

Keywords

ionising radiationpatient awarenesspatient knowledge

Outcome Measures

Primary Outcomes (1)

  • Self-reported knowledge of patients undergoing bone scan or FDG PET/CT

    Self-administered questionnaire will be used to collect information on patient knowledge regarding exposure to ionising radiation when having the nuclear medicine scans such as bone scan or FDG PET/CT

    9 months

Secondary Outcomes (2)

  • Qualitative assessment on current leaflets for bone scans and FDG PET/CT scans

    9 months

  • Demographic correlations with self-reported knowledge

    9 months

Study Arms (2)

Group 1: patients attending for a 99mTc-MDP bone scan.

Group 1: Patients will be approached after they had their injection for the bone scan procedure. Completion of questionnaire will take place during the three hour uptake period, before they have the scan.

Other: Self-administered questionnaire

Group 2: patients attending for a 18F- FDG PET/CT scan.

Group 2: Patients will be approached and consented after they had their injection and scan for 18F- FDG PET/CT. Completion of questionnaire will take place immediately after patients have changed and wait to leave the department, while they wait for their scan to be checked .

Other: Self-administered questionnaire

Interventions

Self-administered questionnaire

Group 1: patients attending for a 99mTc-MDP bone scan.Group 2: patients attending for a 18F- FDG PET/CT scan.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Group 1: patients attending 99mTc-MDP bone scans. Group 2: patients attending 18F- FDG PET/CT scans.

You may qualify if:

  • Over the age of 18
  • Group 1: undergoing a diagnostic bone scan within the Nuclear Medicine and PET/CT Department at The Royal Marsden Hospital
  • Group 2: undergoing a diagnostic 18F- FDG PET/CT within the Nuclear Medicine and PET/CT Department at The Royal Marsden Hospital.

You may not qualify if:

  • Previous participation in one group; (participants can only take part in one of the group questionnaires once).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Royal Marsden Hospital NHS Trust Foundation

Sutton, Surrey, SM2 5PT, United Kingdom

Location

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 20, 2018

First Posted

March 8, 2018

Study Start

February 26, 2018

Primary Completion

December 31, 2018

Study Completion

December 31, 2018

Last Updated

June 29, 2018

Record last verified: 2018-03

Locations